Active Ingredient: Repaglinide Diabetes mellitus, type 2: To improve glycemic control in adults with type 2 diabetes mellitus (noninsulin dependent) as an adjunct to diet and exercise
Guideline recommendations: Meglitinides (eg, repaglinide) are generally not used in patients with type 2 diabetes except in specific situations, such as patients with irregular meal schedules, those who develop late postprandial hypoglycemia when taking a sulfonylurea, or instead of a sulfonylurea in patients with sulfa allergies